104 related articles for article (PubMed ID: 27249594)
1. Expression of LRIG1 in pituitary tumor and its clinical significance.
Jie G; Guozheng X; Ying L; Yi Z; Bo D
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1969-73. PubMed ID: 27249594
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line.
Guo D; Han L; Shu K; Chen J; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):91-4. PubMed ID: 17393120
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro.
Cheng SQ; Fan HY; Xu X; Gao WW; Lv SG; Ye MH; Wu MJ; Shen XL; Cheng ZJ; Zhu XG; Zhang Y
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):558-563. PubMed ID: 27465333
[TBL] [Abstract][Full Text] [Related]
4. [LRIG1 promotes the apoptosis of pituitary tumor cells induced by cisplatin].
Zhou L; Bao C; Hu X; Dai Y; Bao Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):9-15. PubMed ID: 29595451
[TBL] [Abstract][Full Text] [Related]
5. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
[TBL] [Abstract][Full Text] [Related]
6. Leucine-rich repeats and immunoglobulin-like domains protein 1 and fascin actin-bundling protein 1 expression in nonsmall cell lung cancer.
Zhang J; Wang X; Zhang Y; Wu J; Zhou N
J Cancer Res Ther; 2016 Dec; 12(Supplement):C248-C251. PubMed ID: 28230028
[TBL] [Abstract][Full Text] [Related]
7. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of subcutaneously implanted human pituitary tumor cells in nude mice by LRIG1.
Wang X; He XJ; Xu HQ; Chen ZW; Fan HH
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173312
[TBL] [Abstract][Full Text] [Related]
9. Loss of Lrig1 leads to expansion of Brunner glands followed by duodenal adenomas with gastric metaplasia.
Wang Y; Shi C; Lu Y; Poulin EJ; Franklin JL; Coffey RJ
Am J Pathol; 2015 Apr; 185(4):1123-34. PubMed ID: 25794708
[TBL] [Abstract][Full Text] [Related]
10. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract][Full Text] [Related]
11. LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking.
Lindström AK; Ekman K; Stendahl U; Tot T; Henriksson R; Hedman H; Hellberg D
Int J Gynecol Cancer; 2008; 18(2):312-7. PubMed ID: 17624990
[TBL] [Abstract][Full Text] [Related]
12. LRIG1 as a potential novel marker for neoplastic transformation in ocular surface squamous neoplasia.
Nagata M; Nakamura T; Sotozono C; Inatomi T; Yokoi N; Kinoshita S
PLoS One; 2014; 9(4):e93164. PubMed ID: 24709893
[TBL] [Abstract][Full Text] [Related]
13. LRIG1 expression in colorectal cancer.
Ljuslinder I; Golovleva I; Palmqvist R; Oberg A; Stenling R; Jonsson Y; Hedman H; Henriksson R; Malmer B
Acta Oncol; 2007; 46(8):1118-22. PubMed ID: 17851870
[TBL] [Abstract][Full Text] [Related]
14. LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.
Thomasson M; Wang B; Hammarsten P; Dahlman A; Persson JL; Josefsson A; Stattin P; Granfors T; Egevad L; Henriksson R; Bergh A; Hedman H
Int J Cancer; 2011 Jun; 128(12):2843-52. PubMed ID: 21128282
[TBL] [Abstract][Full Text] [Related]
15. Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1.
Li F; Ye ZQ; Guo DS; Yang WM
Oncol Rep; 2011 Aug; 26(2):439-46. PubMed ID: 21567105
[TBL] [Abstract][Full Text] [Related]
16. [Differential expression of DJ-1 and HSP27 in invasive and non-invasive pituitary adenomas].
Chen W; Shi X; Liu Y; Li C; Xiao Z; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):481-4. PubMed ID: 22659660
[TBL] [Abstract][Full Text] [Related]
17. Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) is downregulated in Invasive ductal carcinoma and potential prognostic marker of breast cancer.
Piracha ZZ; Saeed U
J Cancer Res Ther; 2023 Oct; 19(7):1870-1879. PubMed ID: 38376291
[TBL] [Abstract][Full Text] [Related]
18. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
[TBL] [Abstract][Full Text] [Related]
19. Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
Mao JH; Guo H; Si N; Qiu L; Guo LF; Sun ZS; Xiang Y; Yang XH; Zhao WG; Zhang WC
Genet Mol Res; 2015 Dec; 14(4):17091-8. PubMed ID: 26681056
[TBL] [Abstract][Full Text] [Related]
20. The identification of human pituitary adenoma-initiating cells.
Manoranjan B; Mahendram S; Almenawer SA; Venugopal C; McFarlane N; Hallett R; Vijayakumar T; Algird A; Murty NK; Sommer DD; Provias JP; Reddy K; Singh SK
Acta Neuropathol Commun; 2016 Nov; 4(1):125. PubMed ID: 27894339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
